-
公开(公告)号:DK2740790T3
公开(公告)日:2017-02-20
申请号:DK12819778
申请日:2012-07-18
Applicant: FUSO PHARMACEUTICAL IND
Inventor: YAO TATSUMA , ASAYAMA YUTA , MATSUHISA AKIO
IPC: C12N5/073 , C08K5/00 , C08L101/00
-
公开(公告)号:PT1939287T
公开(公告)日:2017-02-03
申请号:PT06781980
申请日:2006-07-31
Applicant: FUSO PHARMACEUTICAL IND , MASARU OKABE , IKAWA MASAHITO
Inventor: MASARU OKABE , MASAHITO IKAWA
IPC: C12N15/86
-
公开(公告)号:AU2014312881A1
公开(公告)日:2016-04-07
申请号:AU2014312881
申请日:2014-08-27
Applicant: TAISEI KAKO CO , FUSO PHARMACEUTICAL IND , 3 D MATRIX LTD
Inventor: HORITA TAIJI , MATSUMOTO IPPEI , SONOYAMA TOMOYUKI , NISHIOKA FUKUMITSU , TANIOKA SHOUJIROU , NOHARA MASAHIRO , TAKANO KIYOSHI
Abstract: Provided are a syringe and a syringe set. The syringe can be readily distinguished from other syringes simply by looking at a tip section thereof. The syringe comprises: the tip section (15) having an external diameter of 4.315-6 mm and provided at an end of a barrel main body (11) having a drug filled therein; a peripheral wall section (18) provided on the outer circumference of the tip section (15) and concentrically with the tip section (15); and a helical rib (19) provided on an inner surface of the peripheral wall section (18) or the outer surface of the tip section (15).
-
74.
公开(公告)号:CA2726161C
公开(公告)日:2015-09-08
申请号:CA2726161
申请日:2009-06-15
Applicant: UNIV KINKI , FUSO PHARMACEUTICAL IND
Inventor: KAWABATA ATSUFUMI , NISHIKAWA HIROYUKI , KAWAI KENZO
Abstract: A composition for promoting lacrimal secretion which can be used safely and effectively in the lacrimal secretion promoting therapy, not in the conventional supplemental therapy of lacrimal fluid components is provided. The composition for promoting lacrimal secretion comprising a peptide derivative represented by the formula (I): (see above formula I) and a contact lens which retains and/or contains the composition are provided.
-
公开(公告)号:AU2015203727A1
公开(公告)日:2015-07-30
申请号:AU2015203727
申请日:2015-07-02
Applicant: FUSO PHARMACEUTICAL IND , UNIV MIYAZAKI
Inventor: MUGURUMA MICHIO , MURATA HIROSHI
IPC: C08B37/10 , A61K31/727 , A61P7/02 , A61P9/00 , A61P9/10 , A61P9/12 , A61P21/00 , A61P29/00 , A61P35/04 , A61P37/06 , A61P37/08
Abstract: Abstract The present invention provides a high purity heparin 5 useful to be a pharmaceutical product, cosmetics, research reagent, or the like, and a method for producing the same, more specifically, a heparin which does not substantially contain a nitrous acid degradation resistant impurity and a method for producing a heparin, 10 comprising mixing an aqueous solution of 5 to 30% by weight of the heparin with ethanol having an amount (volume) 0.2 to 1 times the amount (volume) of the aqueous heparin solution to obtain a colloidal precipitate of heparin.
-
公开(公告)号:PT2380979E
公开(公告)日:2015-06-26
申请号:PT09834882
申请日:2009-12-22
Applicant: UNIV HOKKAIDO NAT UNIV CORP , FUSO PHARMACEUTICAL IND
Inventor: SUZUKI YUSUKE , TAHARA HIROSHI , YAMAMOTO KEIICHI , KITAHARA YUZURU , SUZUKI YASUHIKO
-
77.
公开(公告)号:ES2536198T3
公开(公告)日:2015-05-21
申请号:ES09834882
申请日:2009-12-22
Applicant: UNIV HOKKAIDO NAT UNIV CORP , FUSO PHARMACEUTICAL IND
Inventor: SUZUKI YUSUKE , TAHARA HIROSHI , YAMAMOTO KEIICHI , KITAHARA YUZURU , SUZUKI YASUHIKO
Abstract: Una proteína recombinante que tiene una estructura de hélice triple, que comprende una proteína codificada por un polinucleótido que comprende (i) a (v) a continuación en orden desde el terminal amino: (i) un gen de dominio de péptido de señalización de colectina humana; (ii) un gen de domino rico en cisteína de colectina humana; (iii) un gen de dominio de colágeno de colágeno humano; (iv) un gen de dominio de cuello de colectina humana; y (v) un gen de dominio de reconocimiento de carbohidratos de colectina humana.
-
公开(公告)号:CA2922816A1
公开(公告)日:2015-03-05
申请号:CA2922816
申请日:2014-08-27
Applicant: TAISEI KAKO CO , FUSO PHARMACEUTICAL IND , 3 D MATRIX LTD
Inventor: HORITA TAIJI , MATSUMOTO IPPEI , SONOYAMA TOMOYUKI , NISHIOKA FUKUMITSU , TANIOKA SHOUJIROU , NOHARA MASAHIRO , TAKANO KIYOSHI
Abstract: Provided are a syringe and a syringe set. The syringe can be readily distinguished from other syringes simply by looking at a tip section thereof. The syringe comprises: the tip section (15) having an external diameter of 4.315-6 mm and provided at an end of a barrel main body (11) having a drug filled therein; a peripheral wall section (18) provided on the outer circumference of the tip section (15) and concentrically with the tip section (15); and a helical rib (19) provided on an inner surface of the peripheral wall section (18) or the outer surface of the tip section (15).
-
公开(公告)号:CA2701249C
公开(公告)日:2014-12-16
申请号:CA2701249
申请日:2008-10-06
Applicant: FUSO PHARMACEUTICAL IND , UNIV CHIBA NAT UNIV CORP
Inventor: ODA SHIGETO , SADAHIRO TOMOHITO , NAKAMURA MASATAKA , TANAKA SYUICHI , TOKUOKA SHOGO , OTANI HIROYA
IPC: A61K33/42 , A61K31/7004 , A61K33/10 , A61K33/14 , A61P7/08
Abstract: The invention relates to a stable bicarbonate ion-containing drug solution, particularly a bicarbonate-containing drug solution for dialysis in which the stability has been improved by the presence of a phosphate ion. Further, the invention relates to a drug solution for acute blood purification, particularly a dialysate and a substitution liquid for acute blood purification to be mixed before use containing the drug solution. Still further, the invention relates to a dialysate and a substitution liquid for acute blood purification to be mixed before use in which the formation of insoluble fine particles or precipitates is prevented for a long time after mixing and with which hypokalemeia and hypophosphatemia are not caused.
-
80.
公开(公告)号:AU2008292375B2
公开(公告)日:2014-07-03
申请号:AU2008292375
申请日:2008-08-29
Applicant: UNIV OSAKA PREFECTURE , FUSO PHARMACEUTICAL IND
Inventor: YAMASAKI SHINJI , ASAKURA MASAHIRO , SAMOSORUNSUK WORADA
IPC: C12N15/09 , C07K14/205 , C07K16/12 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12P21/02 , C12Q1/68 , G01N33/569
Abstract: Disclosed are: a cytolethal distending toxin (CDT) derived from
-
-
-
-
-
-
-
-
-